The term HoxD8 Inhibitors refers to a specific class of chemical compounds that exhibit inhibitory effects on the HoxD8 gene. HoxD8, a member of the Hox gene family, plays a crucial role in the regulation of embryonic development and pattern formation in various organisms, including humans. The Hox gene family encodes transcription factors that control the spatial organization of cells and tissues along the anterior-posterior axis during embryonic development. HoxD8, specifically, is involved in the development of the skeletal system and is essential for proper limb formation.
The inhibitors targeting HoxD8 are designed to modulate the activity of this gene, thereby influencing the downstream processes governed by its expression. These inhibitors typically interact with specific molecular components involved in the HoxD8 regulatory pathway, affecting its transcriptional activity or protein function. Understanding and manipulating the activity of HoxD8 can have profound implications for developmental biology research and may offer insights into the molecular mechanisms underlying skeletal development. Consequently, the study and development of HoxD8 inhibitors contribute to advancing our knowledge of gene regulatory networks and may have potential applications in various fields, although their exact implications remain to be fully elucidated through further research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Targets the Hedgehog signaling pathway, which can interact with homeobox gene regulation. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Inhibits Smoothened, a key protein in the Hedgehog pathway, potentially affecting downstream homeobox gene expression. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor, can alter cell cycle regulation, potentially affecting homeobox gene-dependent development processes. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitor, could alter chromatin accessibility and thus affect HOXD8 transcriptional activity. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Notch pathway inhibitor, which is linked to developmental processes and may interact with homeobox gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, might influence cellular pathways that indirectly regulate homeobox gene activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can affect cell growth and proliferation, potentially impacting HOXD8-related pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, may influence cytoskeletal arrangement and gene expression, with possible indirect effects on HOXD8. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, can affect DNA methylation status and gene expression, including homeobox genes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, can modify chromatin structure and potentially affect transcription of genes including HOXD8. | ||||||